<?xml version="1.0" encoding="UTF-8"?>
<p>To expedite this search for anti-COVID drugs, several computational studies have used homology modeling or published crystal structures of SARS-CoV-2 proteins, molecular docking and diverse small molecule libraries, to predict potential inhibitors of SARS-CoV-2 proteins including among existing approved drugs for repurposing and natural compounds (see e.g., [
 <xref rid="B16-molecules-25-03822" ref-type="bibr">16</xref>,
 <xref rid="B17-molecules-25-03822" ref-type="bibr">17</xref>,
 <xref rid="B18-molecules-25-03822" ref-type="bibr">18</xref>,
 <xref rid="B19-molecules-25-03822" ref-type="bibr">19</xref>,
 <xref rid="B20-molecules-25-03822" ref-type="bibr">20</xref>,
 <xref rid="B21-molecules-25-03822" ref-type="bibr">21</xref>,
 <xref rid="B22-molecules-25-03822" ref-type="bibr">22</xref>,
 <xref rid="B23-molecules-25-03822" ref-type="bibr">23</xref>,
 <xref rid="B24-molecules-25-03822" ref-type="bibr">24</xref>]). In comparison, fewer computational studies [
 <xref rid="B16-molecules-25-03822" ref-type="bibr">16</xref>,
 <xref rid="B19-molecules-25-03822" ref-type="bibr">19</xref>] have focussed on identification of potential inhibitors of host factors. In this work, we perform virtual screening of a large phytochemical library specific to Indian medicinal plants to identify potential natural product inhibitors of TMPRSS2 and cathepsin L.
</p>
